| AffymetrixAffymetrix, Inc.Intellectual/developmental disability genotyping IVD, kit, nucleic acid technique (NAT) | 902150 | Affymetrix, Inc. | Intellectual/developmental disability genotyping IVD, kit, nucleic acid technique (NAT) |
| Birlinn BCR-ABL1 p210 IS Control Panel C240MmqciPhiladelphia chromosome/BCR-ABL transcript IVD, control | v.00 | Mmqci | Philadelphia chromosome/BCR-ABL transcript IVD, control |
| Birlinn BCR-ABL1 p210 IS Panel C230MmqciPhiladelphia chromosome/BCR-ABL transcript IVD, control | v.00 | Mmqci | Philadelphia chromosome/BCR-ABL transcript IVD, control |
| cobas® EZH2 Mutation TestRoche Molecular Systems, Inc.Enhancer of zeste homolog 2 (EZH2) gene mutation IVD, kit, nucleic acid technique (NAT) | 7258321190 | Roche Molecular Systems, Inc. | Enhancer of zeste homolog 2 (EZH2) gene mutation IVD, kit, nucleic acid technique (NAT) |
| cobas® EGFR Mutation Test v2Roche Molecular Systems, Inc.Epidermal growth factor receptor (EGFR) gene mutation/mRNA expression IVD, kit, nucleic acid technique (NAT) | 2.0 | Roche Molecular Systems, Inc. | Epidermal growth factor receptor (EGFR) gene mutation/mRNA expression IVD, kit, nucleic acid technique (NAT) |
| Eonis SCID-SMA kitWallac OyMultiple inborn immunodeficiency/muscular/haematological disorder IVD, kit, nucleic acid technique (NAT) | 3241-001U | Wallac Oy | Multiple inborn immunodeficiency/muscular/haematological disorder IVD, kit, nucleic acid technique (NAT) |
| Eonis SCID-SMA kitWallac OyMultiple inborn immunodeficiency/muscular/haematological disorder IVD, kit, nucleic acid technique (NAT) | 3242-001U | Wallac Oy | Multiple inborn immunodeficiency/muscular/haematological disorder IVD, kit, nucleic acid technique (NAT) |
| GenetiSure Dx Wash Buffer 1Agilent Technologies, Inc.Intellectual/developmental disability genotyping IVD, kit, nucleic acid technique (NAT) | K1201-64305 | Agilent Technologies, Inc. | Intellectual/developmental disability genotyping IVD, kit, nucleic acid technique (NAT) |
| GenetiSure Dx Wash Buffer 2Agilent Technologies, Inc.Intellectual/developmental disability genotyping IVD, kit, nucleic acid technique (NAT) | K1201-64310 | Agilent Technologies, Inc. | Intellectual/developmental disability genotyping IVD, kit, nucleic acid technique (NAT) |
| Genomadix Cube CYP2C19Genomadix IncNucleic acid amplification mastermix kit IVD | 2 | Genomadix Inc | Nucleic acid amplification mastermix kit IVD |
| Genomadix Cube CYP2C19Genomadix IncNucleic acid amplification mastermix kit IVD | 2 | Genomadix Inc | Nucleic acid amplification mastermix kit IVD |
| Idylla CDx MSI TestBiocartis NVMicrosatellite instability IVD, kit, nucleic acid technique (NAT) | v3 | Biocartis NV | Microsatellite instability IVD, kit, nucleic acid technique (NAT) |
| Idylla™ MSI FFPE Reference SetSensID GmbHExogenous DNA/RNA internal control IVD, kit | 2x5 | SensID GmbH | Exogenous DNA/RNA internal control IVD, kit |
| Idylla™ MSI TestBiocartis NVMicrosatellite instability IVD, kit, nucleic acid technique (NAT) | 2 | Biocartis NV | Microsatellite instability IVD, kit, nucleic acid technique (NAT) |
| INTROL CF Panel I ControlMmqciCystic fibrosis IVD, control | v.02 | Mmqci | Cystic fibrosis IVD, control |
| INTROL CF Panel I ControlMmqciCystic fibrosis IVD, control | v.02 | Mmqci | Cystic fibrosis IVD, control |
| Ion TorrentLife Technologies CorporationPCR/NAT negative control IVD | A30320 | Life Technologies Corporation | PCR/NAT negative control IVD |
| ipsogen® JAK2 RGQ PCR KitQIAGEN GmbHJAK2 V617F gene mutation IVD, kit, nucleic acid technique (NAT) | V1 | QIAGEN GmbH | JAK2 V617F gene mutation IVD, kit, nucleic acid technique (NAT) |
| Local Run Manager CF 139 Variant Analysis ModuleIllumina, Inc.Cystic fibrosis IVD, kit, multiplex | 20047009 | Illumina, Inc. | Cystic fibrosis IVD, kit, multiplex |
| Local Run Manager CF 139-Variant 2.0 Micro Analysis ModuleIllumina, Inc.Cystic fibrosis IVD, kit, multiplex | 20072975 | Illumina, Inc. | Cystic fibrosis IVD, kit, multiplex |
| Local Run Manager CF Clinical Sequencing Analysis ModuleIllumina, Inc.Cystic fibrosis IVD, kit, multiplex | 20046734 | Illumina, Inc. | Cystic fibrosis IVD, kit, multiplex |
| MammaPrint FFPEAgendia, Inc.Cancer-related multiple gene mutation/mRNA expression IVD, kit, nucleic acid technique (NAT) | MammaPrint FFPE Microarray | Agendia, Inc. | Cancer-related multiple gene mutation/mRNA expression IVD, kit, nucleic acid technique (NAT) |
| OncoMate MSI Dx Analysis SystemPromega CorporationMicrosatellite instability IVD, kit, nucleic acid technique (NAT) | MD2140 | Promega Corporation | Microsatellite instability IVD, kit, nucleic acid technique (NAT) |
| OncoMate® MSI Dx Assay InstallerPromega CorporationMicrosatellite instability IVD, kit, nucleic acid technique (NAT) | MD4130 | Promega Corporation | Microsatellite instability IVD, kit, nucleic acid technique (NAT) |
| Oncomine™ Dx Express Test DNA ControlLife Technologies CorporationMultiple tissue-associated protein/tumour marker IVD, reagent | A50834 | Life Technologies Corporation | Multiple tissue-associated protein/tumour marker IVD, reagent |